(Q38640003)

5 September 2017

Pharmacologic management of comorbid post-traumatic stress disorder and addictions (English)

1 reference

post-traumatic stress disorder

5 September 2017

0 references

author name string

Daryl Shorter

series ordinal

1

1 reference

PubMed ID

26587796

5 September 2017

John Hsieh

series ordinal

2

1 reference

PubMed ID

26587796

5 September 2017

Thomas R Kosten

series ordinal

3

1 reference

5 September 2017

20 November 2015

1 reference

American Journal on Addictions

5 September 2017

1 reference

5 September 2017

24

1 reference

5 September 2017

8

1 reference

5 September 2017

705-712

1 reference

Posttraumatic stress disorder among substance users from the general population

5 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Posttraumatic stress disorder in the National Comorbidity Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Substance use disorders in patients with posttraumatic stress disorder: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Improving PTSD/substance abuse treatment in the VA: a survey of providers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Excess alcohol consumption and health outcomes: a 6-year follow-up of men over age 50 from the health and retirement study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Health and well being of substance use disorder patients with and without posttraumatic stress disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Suicide risk in patients with anxiety disorders: a meta-analysis of the FDA database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Suicidal ideation and risk factors in primary care patients with anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Association of alcohol and drug use disorders and completed suicide: an empirical review of cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

The moderating role of distress tolerance in the relationship between posttraumatic stress disorder symptom clusters and suicidal behavior among trauma exposed substance users in residential treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Genetics of PTSD: Fear Conditioning as a Model for Future Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Chronic PTSD in Vietnam combat veterans: course of illness and substance abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Emotion circuits in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

The Neurobiology of Addiction: Where We Have Been and Where We Are Going

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Symptom improvement in co-occurring PTSD and alcohol dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Treatment-resistant posttraumatic stress disorder: strategies for intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Olanzapine treatment for post-traumatic stress disorder: an open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Adjunctive risperidone in the treatment of chronic combat-related posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Adjunctive risperidone treatment in post-traumatic stress disorder: a preliminary controlled trial of effects on comorbid psychotic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Daytime prazosin reduces psychological distress to trauma specific cues in civilian trauma posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Morphine use after combat injury in Iraq and post-traumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Exposure therapy for substance abusers with PTSD: translating research to practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Modeling associations between posttraumatic stress symptoms and substance use

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Pain and aberrant drug-related behaviors in medically ill patients with and without histories of substance abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Opioid dependence treatment: options in pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Posttraumatic stress disorder and cannabis use in a nationally representative sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

PTSD contributes to teen and young adult cannabis use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Posttraumatic stress symptom severity predicts marijuana use coping motives among traumatic event-exposed marijuana users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Posttraumatic stress disorder and cannabis use characteristics among military veterans with cannabis dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

The endocannabinoid system: emotion, learning and addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Cannabis and anxiety: a critical review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

A placebo-controlled trial of buspirone for the treatment of marijuana dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Double-blind fluoxetine trial in comorbid MDD-CUD youth and young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Pharmacotherapy for cannabis dependence: how close are we?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Effects of oral THC maintenance on smoked marijuana self-administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Neurocircuitry of addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Yohimbine facilitated acoustic startle in combat veterans with post-traumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

The effect of yohimbine on the extinction of conditioned fear: a role for context.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Pregabalin augmentation of antidepressants in patients with accident-related posttraumatic stress disorder: an open label pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Pilot-controlled trial of D-cycloserine for the treatment of post-traumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Emerging treatments for PTSD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Combining pharmacotherapy with cognitive behavioral therapy: traditional and new approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

D-cycloserine facilitates extinction of conditioned alcohol-seeking behaviour in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

D-cycloserine accelerates the extinction of cocaine-induced conditioned place preference in C57bL/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

D-Cycloserine attenuates reactivity to smoking cues in nicotine dependent smokers: a pilot investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

A synaptic model of memory: long-term potentiation in the hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

Benzodiazepine use in posttraumatic stress disorder among veterans with substance abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJAD.12306

21 January 2018

Identifiers

DOI

10.1111/AJAD.12306

1 reference

5 September 2017

1 reference

PubMed ID

26587796